Undifferentiated Carcinoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children
Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue; Rhabdomyosarcoma, Pelvic; Rhabdomyosarcoma, Abdominal Interventions: Procedure: Abdominal Surgery; Drug: Doxorubicin; Radiation: Intra-Operative Radiation Sponsor: M.D. Anderson Cancer Center Not yet recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2017 Category: Research Source Type: clinical trials
